Daniel F Hanley, MD
Disclosures: Consulting Fee-Neurotrope-Other_Role-Consultant|Consulting Fee-Portola Pharmaceuticals, Inc.-Other_Role-Consultant - 08/17/2021

 

Daniel F. Hanley, MD

Director, Brain Injury Outcomes Division

Professor, Johns Hopkins University School of Medicine
Principal Investigator, Johns Hopkins-Tufts Trial Innovation Center

Deputy Director, Johns Hopkins Institute for Clinical and Translational Research

A leading expert on brain injury, Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996. In 1999, he founded the Division of Brain Injury Outcomes and became the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley is a graduate of Williams College and Cornell University Medical College and has board certification in internal medicine, neurology, and psychiatry. His 35 years in medicine have centered on the areas of clinical trial design, organization, and interpretation of drug and device trials, development of strategic research plans, and FDA regulatory compliance. He was the principal investigator for the NIH-sponsored MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As the principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins-Tufts Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics via well-designed and innovative CTSA clinical trials.

Daniel F. Hanley, MD ([email protected])

Division of Brain Injury Outcomes, JHU-Tufts Trial Innovation Center

Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine

Johns Hopkins University School of Medicine

1550 Orleans St., 3M50 South Baltimore, MD 21287

Tel: 410-614-6996 Fax: 410-502-7869 braininjuryoutcomes.com